Meeting report: Advances in minimal residual disease testing in multiple myeloma 2018
Author:
Affiliation:
1. Myeloma Service; Department of Medicine; Memorial Sloan Kettering Cancer Center; New York New York
2. Department of Clinical and Molecular Medicine; Norwegian University of Science and Technology, NTNU; Trondheim Norway
Funder
Memorial Sloan Kettering Core
Publisher
Hindawi Limited
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/acg2.26/fullpdf
Reference14 articles.
1. Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis;Landgren;Bone Marrow Transplant,2016
2. Association of minimal residual disease with superior survival outcomes in patients with multiple myeloma: a meta-analysis;Munshi;JAMA Oncol,2017
3. MRD testing in multiple myeloma: from a surrogate marker of clinical outcomes to an every-day clinical tool;Landgren;Semin Hematol,2018
4. Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma;Perrot;Blood,2018
5. Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myeloma;Korde;JAMA Oncol,2015
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients;Blood Cancer Journal;2023-03-06
2. Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients;2022-09-20
3. Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma;Annals of Laboratory Medicine;2022-09-01
4. Measurable Residual Disease Assessment in Multiple Myeloma: How Deep Is Enough?;Hemato;2022-06-23
5. Minimal Residual Disease in Multiple Myeloma: Something Old, Something New;Cancers;2021-08-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3